Publications 2018

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2018)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 118 (6), e11
DOI 10.1038/bjc.2017.470, PubMed 29462127

Medlow PW, Steele CJ, McCavigan AM, Reardon W, Brown CM, Lambe SM, Ishiy FAA, Walker SM, Logan GE, Raji OY, Berge V, Katz B, Kay EW, Sheehan K, Watson RW, Harkin DP, Kennedy RD, Knight LA (2018)
Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue
BMC Med Genomics, 11 (1), 125
DOI 10.1186/s12920-018-0442-y, PubMed 30591067

Publications 2017

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2017)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 117 (11), 1656-1664
DOI 10.1038/bjc.2017.346, PubMed 28972967

Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)
Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma
Virchows Arch, 471 (3), 355-362
DOI 10.1007/s00428-017-2172-5, PubMed 28643014

Publications 2016

Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA (2016)
Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
Oncotarget, 7 (2), 1878-94
DOI 10.18632/oncotarget.6479, PubMed 26646591

Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Taskén KA (2016)
PBX3 is a putative biomarker of aggressive prostate cancer
Int J Cancer, 139 (8), 1810-20
DOI 10.1002/ijc.30220, PubMed 27273830

Smogeli E, Davidson B, Cvancarova M, Holth A, Katz B, Risberg B, Kristensen G, Lindemann K (2016)
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
BMC Cancer, 16, 596
DOI 10.1186/s12885-016-2631-4, PubMed 27488577

Publications 2015

Davidson B, Holth A, Hellesylt E, Hadar R, Katz B, Tropé CG, Reich R (2015)
HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival
Hum Pathol, 48, 95-101
DOI 10.1016/j.humpath.2015.09.027, PubMed 26640230

Katz B, Tropé CG, Reich R, Davidson B (2015)
MicroRNAs in Ovarian Cancer
Hum Pathol, 46 (9), 1245-56
DOI 10.1016/j.humpath.2015.06.013, PubMed 26216350

Leite KR, Reis ST, Viana N, Morais DR, Moura CM, Silva IA, Pontes J, Katz B, Srougi M (2015)
Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer
J Cancer, 6 (3), 292-301
DOI 10.7150/jca.11038, PubMed 25663948

Machado MC, Fonseca GM, de Meirelles LR, Siqueira LT, Katz B, Jukemura J (2015)
Synchronous resection of pancreatic serous cystadenocarcinoma and liver metastasis: First reported case and review of literature
Pancreatology, 15 (6), 708-12
DOI 10.1016/j.pan.2015.09.009, PubMed 26463518

Moura CM, Pontes J, Reis ST, Viana NI, Morais DR, Dip N, Katz B, Srougi M, Leite KR (2015)
Expression profile of standard and variants forms of CD44 related to prostate cancer behavior
Int J Biol Markers, 30 (1), e49-55
DOI 10.5301/jbm.5000091, PubMed 24832177

Publications 2014

Dip N, Reis ST, Abe DK, Viana NI, Morais DR, Moura CM, Katz B, Silva IA, Srougi M, Leite KR (2014)
Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma
Int Braz J Urol, 40 (5), 644-9
DOI 10.1590/S1677-5538.IBJU.2014.05.09, PubMed 25498275

Katz B, Reis ST, Viana NI, Morais DR, Moura CM, Dip N, Silva IA, Iscaife A, Srougi M, Leite KR (2014)
Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer
PLoS One, 9 (11), e113700
DOI 10.1371/journal.pone.0113700, PubMed 25409297

Viana NI, Reis ST, Dip NG, Morais DR, Moura CM, Silva IA, Katz B, Srougi M, Leite KR, Antunes AA (2014)
MicroRNAs 143 and 145 may be involved in benign prostatic hyperplasia pathogenesis through regulation of target genes and proteins
Int J Biol Markers, 29 (3), e246-52
DOI 10.5301/jbm.5000069, PubMed 24474452

Publications 2013

Chaux A, Munari E, Katz B, Sharma R, Lecksell K, Cubilla AL, Burnett AL, Netto GJ (2013)
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases
Hum Pathol, 44 (12), 2690-5
DOI 10.1016/j.humpath.2013.07.012, PubMed 24075601

Gonzalez-Roibon N, Katz B, Chaux A, Sharma R, Munari E, Faraj SF, Illei PB, Torbenson M, Netto GJ (2013)
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors
Hum Pathol, 44 (7), 1293-9
DOI 10.1016/j.humpath.2012.10.017, PubMed 23347651

Santos EB, Koff WJ, Grezzana Filho Tde J, De Rossi SD, Treis L, Bona SR, Pêgas KL, Katz B, Meyer FS, Marroni NA, Corso CO (2013)
Oxidative stress evaluation of ischemia and reperfusion in kidneys under various degrees of hypothermia in rats
Acta Cir Bras, 28 (8), 568-73
DOI 10.1590/s0102-86502013000800003, PubMed 23896835

Publications 2012

Katz B, Srougi M, Camara-Lopes LH, Antunes AA, Nesrallah L, Nesrallah A, Dall'Oglio MF, Leite KR (2012)
The accuracy of pathological data for the prediction of insignificant prostate cancer
Int Braz J Urol, 38 (6), 760-8
DOI 10.1590/1677-553820133806760, PubMed 23302398

Publications 2011

Katz B, Srougi M, Dall'Oglio M, Nesrallah AJ, Sant'anna AC, Pontes J, Antunes AA, Reis ST, Viana N, Sañudo A, Camara-Lopes LH, Leite KR (2011)
Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy
Urol Oncol, 31 (2), 175-9
DOI 10.1016/j.urolonc.2010.11.008, PubMed 21795075

Katz B, Srougi M, Dall'Oglio M, Nesrallah AJ, Sant'anna AC, Pontes J, Reis ST, Sañudo A, Camara-Lopes LH, Leite KR (2011)
Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?
Urol Oncol, 30 (6), 794-7
DOI 10.1016/j.urolonc.2010.10.010, PubMed 21458310

Publications 2009

Ludwig HT, Matte B, Katz B, Rohde LA (2009)
Do sluggish cognitive tempo symptoms predict response to methylphenidate in patients with attention-deficit/hyperactivity disorder-inattentive type?
J Child Adolesc Psychopharmacol, 19 (4), 461-5
DOI 10.1089/cap.2008.0115, PubMed 19702499